These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 26743475)
1. microRNA-10b is a prognostic biomarker for melanoma. Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475 [TBL] [Abstract][Full Text] [Related]
2. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas. Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas. Murria Estal R; de Unamuno Bustos B; Pérez Simó G; Simarro Farinos J; Torres Navarro I; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R Melanoma Res; 2021 Feb; 31(1):18-26. PubMed ID: 33234848 [TBL] [Abstract][Full Text] [Related]
4. Quantification of microRNA-21 and microRNA-125b in melanoma tissue. Wandler A; Riber-Hansen R; Hager H; Hamilton-Dutoit SJ; Schmidt H; Nielsen BS; Stougaard M; Steiniche T Melanoma Res; 2017 Oct; 27(5):417-428. PubMed ID: 28614272 [TBL] [Abstract][Full Text] [Related]
5. In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA. Hanna JA; Hahn L; Agarwal S; Rimm DL Lab Invest; 2012 Oct; 92(10):1390-7. PubMed ID: 22890556 [TBL] [Abstract][Full Text] [Related]
6. Expression of microRNA-106b and its clinical significance in cutaneous melanoma. Lin N; Zhou Y; Lian X; Tu Y Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients. Parrella P; Barbano R; Pasculli B; Fontana A; Copetti M; Valori VM; Poeta ML; Perrone G; Righi D; Castelvetere M; Coco M; Balsamo T; Morritti M; Pellegrini F; Onetti-Muda A; Maiello E; Murgo R; Fazio VM Mol Cancer; 2014 Jun; 13():142. PubMed ID: 24897960 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer. Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749 [TBL] [Abstract][Full Text] [Related]
9. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma. Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999 [TBL] [Abstract][Full Text] [Related]
10. A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients. Ono S; Oyama T; Lam S; Chong K; Foshag LJ; Hoon DS Oncotarget; 2015 Mar; 6(9):7053-64. PubMed ID: 25749524 [TBL] [Abstract][Full Text] [Related]
11. Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma. Wang C; Guan S; Liu F; Chen X; Han L; Wang D; Nesa EU; Wang X; Bao C; Wang N; Cheng Y Br J Cancer; 2016 Feb; 114(3):290-7. PubMed ID: 26794279 [TBL] [Abstract][Full Text] [Related]
12. Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma. Dika E; Riefolo M; Porcellini E; Broseghini E; Ribero S; Senetta R; Osella-Abate S; Scarfì F; Lambertini M; Veronesi G; Patrizi A; Fanti PA; Ferracin M J Invest Dermatol; 2020 Nov; 140(11):2260-2267. PubMed ID: 32275975 [TBL] [Abstract][Full Text] [Related]
13. Sensitive detection of melanoma metastasis using circulating microRNA expression profiles. Shiiyama R; Fukushima S; Jinnin M; Yamashita J; Miyashita A; Nakahara S; Kogi A; Aoi J; Masuguchi S; Inoue Y; Ihn H Melanoma Res; 2013 Oct; 23(5):366-72. PubMed ID: 23863473 [TBL] [Abstract][Full Text] [Related]
14. Microrna profiling analysis of differences between the melanoma of young adults and older adults. Jukic DM; Rao UN; Kelly L; Skaf JS; Drogowski LM; Kirkwood JM; Panelli MC J Transl Med; 2010 Mar; 8():27. PubMed ID: 20302635 [TBL] [Abstract][Full Text] [Related]
16. Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. Hwang JH; Voortman J; Giovannetti E; Steinberg SM; Leon LG; Kim YT; Funel N; Park JK; Kim MA; Kang GH; Kim SW; Del Chiaro M; Peters GJ; Giaccone G PLoS One; 2010 May; 5(5):e10630. PubMed ID: 20498843 [TBL] [Abstract][Full Text] [Related]
17. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression. van Kempen LC; van den Hurk K; Lazar V; Michiels S; Winnepenninckx V; Stas M; Spatz A; van den Oord JJ Virchows Arch; 2012 Oct; 461(4):441-8. PubMed ID: 22956368 [TBL] [Abstract][Full Text] [Related]
18. Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma. Tian R; Liu T; Qiao L; Gao M; Li J Int J Clin Exp Pathol; 2015; 8(3):3097-103. PubMed ID: 26045823 [TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer. Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409 [TBL] [Abstract][Full Text] [Related]
20. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma. Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]